Debra Zack - 01 Mar 2022 Form 4 Insider Report for EXAGEN INC. (XGN)

Reporting relationship: Chief Medical Officer
Issuer ticker: XGN
Reported as of: 01 Mar 2022
Net transaction value: -$23,076
SEC form: 4
Accepted by SEC: 02 Mar 2022, 15:41:04 UTC
Prior SEC filing: 08 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Kamal Adawi, as attorney-in-fact

Key filing fact

Debra Zack filed Form 4 for EXAGEN INC. (XGN) on 02 Mar 2022.

Key facts

This page summarizes Debra Zack's Form 4 filing for EXAGEN INC. (XGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Mar 2022, 15:41.

Change

Previous filing in this sequence was filed on 08 Feb 2022.
Current net transaction value: -$23,076.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XGN transaction

Common Stock

Tax liability

Transaction value: $23,076
Shares: -3,241
Change %: -3.7%
Price: $7.12
Shares after: 84,259
Date: 01 Mar 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares were withheld from the Reporting Person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted on February 23, 2021.